Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 48, Issue 22, pp. 6593-6596
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 21, 1988
- Revision received June 7, 1988
- Accepted August 3, 1988
- Published first November 1, 1988.
Copyright & Usage
©1988 American Association for Cancer Research.
Author Information
- Janet R. Hardy,
- Vernon J. Harvey2,
- James W. Paxton,
- Pandora Evans,
- Shelba Smith,
- William Grove,
- Antonio J. Grillo-Lopez, and
- Bruce C. Baguley
- Department of Clinical Oncology, Auckland Hospital [J. R. H., V. J. H., S. S.], Department of Pharmacology, University of Auckland School of Medicine [J. W. P., P. E.], and Cancer Research Laboratory, University of Auckland School of Medicine [B. C. B.], Auckland, New Zealand; and Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company [W. G., A. J. G-L.], Ann Arbor, Michigan 48105
November 1988
Volume 48, Issue 22
Volume 48, Issue 22
Phase I Trial of the Amsacrine Analogue 9-({2-Methoxy-4-[(methylsulfonyl)amino]-phenyl}]amino)-N,5-dimethyl-4-acridinecarboxamide (CI-921)
Jump to section
Advertisement